BIOGEN INC. Stock Repurchase Program, Number of Shares Authorized to be Repurchased
BIOGEN INC. (BIIB) had Stock Repurchase Program, Number of Shares Authorized to be Repurchased of 1.30 million shares as of 2016-12-31, per its 10-K filed 2017-02-02.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2017-02-02
- 2016-12-31: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 1.30M shares.
- 2016-09-30: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 1.30M shares.
- 2016-06-30: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 1.30M shares.
- 2015-12-31: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 1.30M shares.
| Period end | Stock Repurchase Program, Number of Shares Authorized to be Repurchased |
|---|---|
| 2016-12-31 | 1.30M shares 10-K · filed 2017-02-02 |
| 2016-09-30 | 1.30M shares 10-Q · filed 2016-10-26 |
| 2016-06-30 | 1.30M shares 10-Q · filed 2016-07-21 |
| 2015-12-31 | 1.30M shares 10-K · filed 2016-02-03 |
| 2015-03-31 | 1.30M shares 10-Q · filed 2015-04-24 |
| 2014-12-31 | 1.30M shares 10-K · filed 2015-02-04 |
| 2014-09-30 | 2.90M shares 10-Q · filed 2014-10-22 |
| 2014-06-30 | 3.00M shares 10-Q · filed 2014-07-23 |
| 2014-03-31 | 4.20M shares 10-Q · filed 2014-04-23 |
| 2013-12-31 | 4.20M shares 10-K · filed 2014-02-06 |
| 2013-09-30 | 4.20M shares 10-Q · filed 2013-10-28 |
| 2013-06-30 | 5.90M shares 10-Q · filed 2013-07-25 |
| 2013-03-31 | 5.90M shares 10-Q · filed 2013-04-25 |
| 2012-12-31 | 6.20M shares 10-K · filed 2013-02-05 |
| 2012-09-30 | 6.30M shares 10-Q · filed 2012-10-25 |
| 2012-06-30 | 6.30M shares 10-Q · filed 2012-07-24 |
| 2011-03-31 | 20.00M shares 10-K · filed 2017-02-02 |
| 2011-02-28 | 20.00M shares 10-Q · filed 2015-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |